Health
UPDATE 2-Regeneron to stop enrolling very sick COVID-19 patients in antibody trial – Reuters
Regeneron Pharmaceuticals said on Friday it would stop enrolling patients receiving advanced COVID-19 care in a trial testing its experimental antibody treatment…
FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid
(Reuters) – Regeneron Pharmaceuticals said on Friday it would stop enrolling patients receiving advanced COVID-19 care in a trial testing its experimental antibody treatment in hospitalized patients, based on the recommendation of an independent safety board.
The recommendation was based on a potential safety signal…
-
General17 hours agoCarrie Bickmore named Victorian Australian of the Year for work to progress brain cancer research
-
Noosa News21 hours agoToddler dies after vehicle accident on rural property in Abergowrie
-
Noosa News21 hours agoMale nurse charged with raping two elderly women at Greenslopes hospital
-
Business23 hours ago5 most popular Vanguard ASX ETFs among Aussie investors in 2025